CRP has been shown to be a reliable biomarker for COPD in systemic inflammation responses and cardiovascular events [44], however, it is not good marker for predicting pneumonia in COPD patients with ICS treatment. This evidence concerns the gene CRP and chronic obstructive pulmonary disease.